1) Lee CM, Afshari NA. The global state of cataract blindness. Curr Opin Ophthalmol 2017;28:98-103.
3) Shingleton BJ, Wadhwani RA, O’Donoghue MW, et al. Evaluation of intraocular pressure in the immediate period after phacoemulsification. J Cataract Refract Surg 2001;27:524-7.
4) Altıntaş AK, Ciritoğlu MY, BeyazyıldıZ Ö, et al. Toxic anterior segment syndrome outbreak after cataract surgery triggered by viscoelastic substance. Middle East Afr J Ophthalmol 2017;24:43-7.
6) Dana MR, Chatzistefanou K, Schaumberg DA, Foster CS. Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology 1997;104:1387-93.
7) Ebihara Y, Kato S, Oshika T, et al. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg 2006;32:1184-7.
8) Juthani VV, Clearfield E, Chuck RS. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database Syst Rev 2017;7:CD010516.
9) Havener W. Ocular pharmacology. 4th ed. Missouri: Mosby Co., 1978;433-500.
10) Schultz T, Joachim SC, Szuler M, et al. NSAID Pretreatment inhibits prostaglandin release in femtosecond laser-assisted cataract surgery. J Refract Surg 2015;31:791-4.
11) Kim SJ, Schoenberger SD, Thorne JE, et al. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology 2015;122:2159-68.
12) Quintana NE, Allocco AR, Ponce JA, Magurno MG. Non steroidal anti-inflammatory drugs in the prevention of cystoid macular edema after uneventful cataract surgery. Clin Ophthalmol 2014;8:1209-12.
14) Masis M, Mineault PJ, Phan E, Lin SC. The role of phacoemulsification in glaucoma therapy: a systematic review and meta-analysis. Surv Ophthalmol 2018;63:700-10.
15) Boimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: the PESO study. J Glaucoma 2013;22:730-5.
18) Bonnell LN, SooHoo JR, Seibold LK, et al. One-day postoperative intraocular pressure spikes after phacoemulsification cataract surgery in patients taking tamsulosin. J Cataract Refract Surg 2016;42:1753-8.
19) Slabaugh MA, Bojikian KD, Moore DB, Chen PP. Risk factors for acute postoperative intraocular pressure elevation after phacoemulsification in glaucoma patients. J Cataract Refract Surg 2014;40:538-44.
21) Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. Arch Ophthalmol 1993;111:831-6.
22) Skalicky SE, Martin KR, Fenwick E, et al. Cataract and quality of life in patients with glaucoma. Clin Exp Ophthalmol 2015;43:335-41.
23) Holló G, Aung T, Cantor LB, Aihara M. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol 2020;65:496-512.
24) Joaquin-Quino RM, Khu PM, Florcruz NVD, Sarol JN. Risk of visual loss in advanced glaucoma after trabeculectomy and combined cataract surgery. Philipp J Ophthalmol 2006;31:8-13.
25) Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci 2012;53:241-7.
26) Gu WM, Lim SH, Cha SC. Risk factors for early postoperative intraocular pressure elevation after phacoemulsification in trabeculectomized eyes. J Korean Ophthalmol Soc 2014;55:1659-68.
27) Chen PP, Weaver YK, Budenz DL, et al. Trabeculectomy function after cataract extraction. Ophthalmology 1998;105:1928-35.
28) Akbari M, Moghadam RS, Mohamadpour A. Are topical nonsteroidal anti-inflammatory drugs effective on cataract surgery outcome in pseudoexfoliation syndrom? Int J Med Invest 2021;10:50-61.
29) Belovay GW, Varma DK, Ahmed II. Cataract surgery in pseudoexfoliation syndrome. Curr Opin Ophthalmol 2010;21:25-34.
30) Sangal N, Chen TC. Cataract surgery in pseudoexfoliation syndrome. Semin Ophthalmol 2014;29:403-8.